These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14733065)

  • 1. [Topical immunomodulators for treatment of eczema].
    Heine G; Sterry W; Worm M
    Wien Med Wochenschr; 2003; 153(23-24):522-5. PubMed ID: 14733065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing paradigms in dermatology: topical immunomodulators within a permutational paradigm for the treatment of atopic and eczematous dermatitis.
    Abramovits W; Goldstein AM; Stevenson LC
    Clin Dermatol; 2003; 21(5):383-91. PubMed ID: 14678718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapies for atopic eczema.
    Worm M
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1596-603. PubMed ID: 12476959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is new in atopic dermatitis/eczema?
    Plötz SG; Wiesender M; Todorova A; Ring J
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):441-58. PubMed ID: 25286776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases.
    Bornhövd EC; Burgdorf WH; Wollenberg A
    Curr Opin Investig Drugs; 2002 May; 3(5):708-12. PubMed ID: 12090543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S; Remitz A; Kyllönen H; Saarikko J
    Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in atopic eczema?
    Plötz SG; Ring J
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):249-67. PubMed ID: 20433363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eczema molluscatum in tacrolimus treated atopic dermatitis.
    Wetzel S; Wollenberg A
    Eur J Dermatol; 2004; 14(1):73-4. PubMed ID: 14965804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nonsteroidal topical immunomodulators for the treatment of atopic dermatitis in the pediatric population.
    Paller AS
    J Pediatr; 2001 Feb; 138(2):163-8. PubMed ID: 11174611
    [No Abstract]   [Full Text] [Related]  

  • 11. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K; Jarvis B
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimecrolimus: a review.
    Gupta AK; Chow M
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokine research opens new therapeutic possibilities. Symposium: "Atopic dermatitis: New pathogenetic and therapeutic views", Vienna, 18 May 1993].
    Fortschr Med Suppl; 1993; 149():1-8. PubMed ID: 9260318
    [No Abstract]   [Full Text] [Related]  

  • 15. The economics of topical immunomodulators for the treatment of atopic dermatitis.
    Abramovits W; Boguniewicz M; Paller AS; Whitaker-Worth DL; Prendergast MM; Tokar M; Tong KB
    Pharmacoeconomics; 2005; 23(6):543-66. PubMed ID: 15960552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical immunomodulators for atopic dermatitis.
    Bernard LA; Eichenfield LF
    Curr Opin Pediatr; 2002 Aug; 14(4):414-8. PubMed ID: 12130904
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.
    Sheu MY; Fowler AJ; Kao J; Schmuth M; Schoonjans K; Auwerx J; Fluhr JW; Man MQ; Elias PM; Feingold KR
    J Invest Dermatol; 2002 Jan; 118(1):94-101. PubMed ID: 11851881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.